A SECRET WEAPON FOR BREAST CANCER RESEARCH

However, In spite of this achievement, metastatic HER2+ tumours inevitably acquire resistance, leading to disease progression. As a result, the intention of therapy in HER2+ BC is usually to broaden the volume of patients cured during the early setting and stop recurrence. In those HER2+ cancers that do existing with de novo phase IV disorder or i